Rezilient key facts
- Operator of a telehealth platform intended to offer remote access to in-person care and other healthcare.
- Rezilient’s last known valuation is $47.0M.
- It has raised $14.0M; the latest was Later Stage VC ($10.0M) in Sep 2024.
- Notable investors include Techstars, Matter (Consulting Services (B2B)), Missouri Technology Corporation, Bridge Ventures (Chicago), Acorn Pacific Ventures — 20 tracked in total.
- Status: Privately Held (backing).
Who backs Rezilient
20+- ·The complete investor list: 20 names
- ·Watch Rezilient: the Monday email on marks, rounds and moves
Rezilient funding rounds
No funding rounds for Rezilient are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Rezilient valuation
Rezilient's last known valuation is $47 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
Rezilient investors
20 investors are on record for Rezilient, including Techstars, Matter (Consulting Services (B2B)), Missouri Technology Corporation and Bridge Ventures (Chicago).
About Rezilient
Operator of a telehealth platform intended to offer remote access to in-person care and other healthcare. The company's platform allows doctors to remotely control the positioning of medical devices in real-time to perform exams previously impossible to do remotely bringing the convenience of telehealth with the broad scope of in-person care, enabling individuals and families to get virtual access to their doctor as well as physical exams, labs and imaging.
- Sector
- Healthcare
- HQ
- Saint Louis, MO, United States
- Founded
- 2016
- Employees
- 18
- Website
- rezilienthealth.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Rezilient’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.